CHLORPROMAZINE HYDROCHLORIDE
- Product NDC
- 70518-3321
- Requested package NDC
- 70518-3321-0
- 11-digit product format
- 705183321
- Labeler code
- 70518
- Product ID
- 70518-3321_d4dd2e80-32cc-6b13-e053-2a95a90aab2d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CHLORPROMAZINE HYDROCHLORIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA209755
- Marketing category
- ANDA
- Marketing start
- 2021-12-29
- Marketing end
- 0000-00-00
- Substance
- CHLORPROMAZINE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Phenothiazines [CS],Phenothiazine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-3321 | 70518-3321-0 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209755-001 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-09-10 | |
| A209755-002 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2018-09-10 | |
| A209755-003 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2018-09-10 | |
| A209755-004 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2018-09-10 | |
| A209755-005 | CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2018-09-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209755-001 | AB |
| A209755-002 | AB |
| A209755-003 | AB |
| A209755-004 | AB |
| A209755-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209755-001 | CHLORPROMAZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-09-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209755-002 | CHLORPROMAZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2018-09-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209755-003 | CHLORPROMAZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 2018-09-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209755-004 | CHLORPROMAZINE HYDROCHLORIDE | 100MG | TABLET / ORAL | AB | 2018-09-10 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A209755-005 | CHLORPROMAZINE HYDROCHLORIDE | 200MG | TABLET / ORAL | AB | 2018-09-10 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209755-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209755-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209755-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209755-004 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A209755-005 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | Amneal Pharmaceuticals NY LLC | aa086a21-de85-4b03-af58-49b70acf8cf0 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | 209755 ANDA209755 |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | AvPAK | 9e8cebc0-7fcf-dca8-e053-2a95a90a3369 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 209755 ANDA209755 |
| CHLORPROMAZINE HYDROCHLORIDE | CHLORPROMAZINE HYDROCHLORIDE | American Health Packaging | d43718e5-66d7-44f9-9fc8-80d38d3e41ce | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 209755 ANDA209755 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70518-3321-0 | 70518332100 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-3321-0) | 2021-12-29 | 0000-00-00 | No | No | Current |